At 4.1% CAGR, the Middle East & Africa Enteral and Parenteral Medical Nutrition Market is projected to be worth US$ 661.18 million by 2028, says Business Market Insights

According to Business Market Insights research, the Middle East & Africa enteral and parenteral medical nutrition market was valued at US$ 539.80 million in 2023 and is expected to reach US$ 661.18 million by 2028, registering a CAGR of 4.1% from 2023 to 2028. Rise in prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births are the critical factors attributed to the Middle East & Africa enteral and parenteral medical nutrition market expansion.        

Companies operating in the enteral and parenteral medical nutrition market constantly focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the enteral and parenteral medical nutrition market are mentioned below: In March 2022, Vygon (a specialist single-use medical devices group) acquired Macatt Medica (a distribution company located in Peru). Macatt Medica distributes most of Vygon’s products in Peru, including a range of enteral nutrition products. With the acquisition, Macatt Medica became a fully owned subsidiary of Vygon, supporting the latter’s operations in South America. In September 2021, Abbott introduced plant-based protein and organic food ingredients—PediaSure Harvest and Ensure Harvest—for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements. In December 2020, Abbott launched the Pedialyte Hydration Solution, a new formulation designed with key nutrients to support immune health. Pedialyte with immune support includes prebiotics, vitamin B12, vitamin C, vitamin E, and zinc, specifically chosen for their importance in the development and improvement of the immune system. In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company helps contribute to the real food blends mission and portfolio by bringing more unique and nutritious choices to children and adults dependent on feeding tubes.

Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements; the development of innovative products targeting various health issues; and strategic moves such as expansions and acquisitions allow companies in the enteral and parenteral medical nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.

On the contrary, mechanical, gastrointestinal, and metabolic complications associated with enteral and parenteral feeding systems, and limitations related to catheter placement hampers the Middle East & Africa Enteral and Parenteral Medical Nutrition Market.  

Based on indication, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held 29.7% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 160.17 million. It is projected to garner US$ 198.11 million by 2028 to expand at 4.3% CAGR during 2023–2028.

Based on nutrition type, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 79.3% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$  427.92 million. It is projected to garner US$ 520.64 million by 2028 to expand at 4.0% CAGR during 2023–2028.

Based on form, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held 53.2% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 287.32 million. It is projected to garner US$ 349.58 million by 2028 to expand at 4.0% CAGR during 2023–2028.

Based on product type, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held 57.8% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 312.08 million. It is projected to garner US$ 385.57 million by 2028 to expand at 4.3% CAGR during 2023–2028.

Based on route of administration, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held 44.0% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 237.41 million. It is projected to garner US$ 288.89 million by 2028 to expand at 4.0% CAGR during 2023–2028.

Based on age group, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held 39.5% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 213.25 million. It is projected to garner US$ 262.15 million by 2028 to expand at 4.2% CAGR during 2023–2028.

Based on distribution channel, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held 41.2% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 222.32 million. It is projected to garner US$  269.23 million by 2028 to expand at 3.9% CAGR during 2023–2028.

Based on country, the Middle East & Africa enteral and parenteral medical nutrition market has been categorized into Saudi Arabia, South Africa, the UAE, Iran, Israel, Egypt, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 21.8% share of Middle East & Africa Enteral and Parenteral Medical Nutrition Market in 2023. It was assessed at US$ 117.71 million in 2023 and is likely to hit US$ 140.40 million by 2028, exhibiting a CAGR of 3.6% during the forecast period.

Key players operating in the Middle East & Africa enteral and parenteral medical nutrition market are Abbott Laboratories; B. Braun SE; Baxter International Inc; Easy Line Ltd; Fresenius Kabi AG; Nestle SA; and Nutricia International BV, among others.  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com